CJC-1295 Dosage Guide

What Is the Recommended Dosage for CJC-1295 with DAC?

CJC-1295 with DAC (Drug Affinity Complex) is typically dosed at 100-300 mcg per injection, administered once per week via subcutaneous injection. Most research protocols and user reports suggest that 200 mcg weekly represents a standard "middle-ground" dose that balances efficacy with side effect management. The extended half-life of approximately 8 days allows the peptide to accumulate with consistent weekly dosing, building toward a steady-state level by week 3-4 of use.

Some advanced protocols employ 150 mcg twice weekly (300 mcg total) for more frequent GH stimulation, though this doubles injection frequency. The advantage of the DAC version is convenience—a single injection per week maintains elevated GH levels throughout the week without daily injections. Beginners are typically advised to start with 100 mcg weekly and assess tolerance before moving to 200 mcg or higher.

What Is the Dosage Protocol for CJC-1295 Without DAC?

CJC-1295 without DAC requires a fundamentally different protocol due to its ~30-minute half-life. Standard dosing is 100-300 mcg administered 2-3 times daily via subcutaneous injection. Many users employ a split-dosing approach: 100-150 mcg in the morning, 100-150 mcg in the afternoon, and 100-150 mcg before bed to maintain steady GH elevation throughout the day.

The no-DAC version provides more of an acute GH spike with each injection, mimicking natural GHRH pulses more closely. This can theoretically create a more physiological GH profile, though the requirement for multiple daily injections makes it less convenient than the DAC version. Daily injection frequency also increases needle-site discomfort and the risk of injection-site reactions over time.

Should CJC-1295 Dosage Be Adjusted by Body Weight?

While some GH secretagogues scale with body weight (heavier individuals sometimes use higher doses), most research protocols for CJC-1295 do not employ weight-based dosing. The standard 100-300 mcg range appears to be relatively independent of bodyweight in published studies. However, some practitioners argue that individuals above 220-250 lbs might benefit from 250-300 mcg doses rather than 100-150 mcg, based on the principle that more body mass requires greater GH stimulation for proportional effect.

This is more of a practical guideline than a physiologically defined requirement. Individual variation in receptor sensitivity, dietary intake, training stimulus, and sleep quality likely have greater impact on dosing requirements than bodyweight alone. Starting at 100-150 mcg and titrating upward based on response is a more scientific approach than assuming weight-based dosing from the outset.

What Is the Optimal CJC-1295 Cycle Length?

Most research protocols employ cycle lengths of 8-12 weeks on, followed by 4 weeks off. This pattern aims to maintain receptor sensitivity to GHRH stimulation and avoid potential tachyphylaxis (receptor desensitization). Longer cycles (12-16 weeks) are sometimes used, but the rationale for cycling becomes weaker after 12 weeks, as the biological system has largely adapted to the new GH baseline.

The "off" period (4 weeks) allows the hypothalamic-pituitary-GH axis time to reset and endogenous GHRH receptor expression to potentially upregulate. Many experienced users employ variations like 10 weeks on / 4 weeks off or 12 weeks on / 6 weeks off. The key principle is avoiding indefinite, continuous dosing without breaks, which might theoretically exhaust the body's capacity to respond to GHRH stimulation.

When Should CJC-1295 Be Injected for Optimal Effect?

For CJC-1295 with DAC, injection timing is less critical since the extended half-life means GH elevation is sustained throughout the week. However, many users prefer evening injections (before bed) because natural GH secretion peaks during sleep, and timing the injection to align with the body's circadian GH rhythm may provide a synergistic effect.

For CJC-1295 without DAC, timing is more important. Common protocols split doses into morning (upon waking), afternoon (post-workout or mid-day), and evening (before bed) injections. This spacing aims to maintain relatively consistent GH levels while aligning with natural GH pulse timing. Some advanced users time no-DAC injections to coincide with fasting windows or immediately post-workout when the body is naturally primed to secrete GH.

How Should CJC-1295 Be Dosed When Combined with Ipamorelin?

CJC-1295 and Ipamorelin are commonly stacked because they work synergistically—CJC-1295 stimulates GHRH receptors while Ipamorelin stimulates ghrelin receptors (through a different mechanism). When combined, they produce larger and more frequent GH pulses than either peptide alone. Standard combination dosing is 100-200 mcg CJC-1295 with 100-200 mcg Ipamorelin, typically in the same injection or immediately sequential injections.

For CJC-1295 with DAC + Ipamorelin with DAC, this combination can be administered once weekly (or split twice weekly). For no-DAC versions, both are injected multiple times daily. The synergistic effect of the combination is significant—users often report better results with 100 mcg of each combined than with 200 mcg of either peptide alone. This combination is widely researched and considered one of the most effective GH secretagogue stacks.

How Is CJC-1295 Reconstituted and Dosed from Powder?

CJC-1295 is typically purchased as lyophilized powder that must be reconstituted with bacteriostatic water or sterile saline before use. A standard vial contains 2 mg (2000 mcg) of powder. Reconstituting with 2 mL of bacteriostatic water creates a concentration of 1000 mcg/mL. A 0.1 mL injection then delivers 100 mcg of CJC-1295, making math straightforward.

Many users prefer 4 mL of bacteriostatic water, creating a concentration of 500 mcg/mL (easier for smaller volume dosing on insulin syringes). Once reconstituted, CJC-1295 should be stored in a refrigerator (2-8°C) and remains stable for 30+ days. Always use sterile syringes and injection techniques to avoid bacterial contamination. The reconstitution process itself does not affect the peptide's potency if sterile technique is maintained.

What Is a Beginner Titration Protocol for CJC-1295?

A conservative approach for first-time CJC-1295 users is to start at 100 mcg of the DAC version once weekly, assess tolerance and response for 2-3 weeks, then increase to 150 mcg weekly. After another 2-3 weeks, dose can be escalated to 200 mcg weekly if desired. This gradual titration approach allows the body to adjust to increased GH levels and helps identify any emerging side effects early.

Throughout the titration period, users should monitor for side effects such as water retention, carpal tunnel-like symptoms, joint discomfort, or metabolic changes. Most side effects are dose-dependent and dose-reversible, so starting low and titrating up provides a safety margin. This conservative approach is especially important for individuals new to GH secretagogues or those with pre-existing metabolic conditions.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions